Kridin, Khalaf
Shihade, Wesal
Weinstein, Orly
Zoller, Lilach
Onn, Erez
Cohen, Arnon
Solomon-Cohen, Efrat
Funding for this research was provided by:
Universität zu Lübeck
Article History
Received: 20 June 2022
Revised: 24 June 2023
Accepted: 27 July 2023
First Online: 29 August 2023
Declarations
:
: The authors declare no competing interests.
: ADC served as an advisor, investigator, or speaker for Abbvie, BI, Dexcel Pharma, Janssen, Novartis, Perrigo, Pfizer, and Rafa. None of the other authors have any conflicts of interest to declare.